Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine.
about
Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deploymentAntimalarial drug resistanceA single amino acid residue can determine the sensitivity of SERCAs to artemisininsPlasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugsIn vitro antimalarial drug susceptibility in Thai border areas from 1998-2003.Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in UgandaA comparison of oral artesunate and artemether antimalarial bioactivities in acute falciparum malariaChloroquine/sulphadoxine-pyrimethamine for gambian children with malaria: transmission to mosquitoes of multidrug-resistant Plasmodium falciparumDeployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria InitiativeA randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancyImproving pharmacokinetic-pharmacodynamic modeling to investigate anti-infective chemotherapy with application to the current generation of antimalarial drugsNonlinear mixed-effects modelling of in vitro drug susceptibility and molecular correlates of multidrug resistant Plasmodium falciparumMefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy numberA database of antimalarial drug resistance.High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.Thrombocytopaenia in pregnant women with malaria on the Thai-Burmese border.Pharmacokinetics of oral doxycycline during combination treatment of severe falciparum malaria.Complex Interactions between soil-transmitted helminths and malaria in pregnant women on the Thai-Burmese border.Arthropod borne disease: the leading cause of fever in pregnancy on the Thai-Burmese border.Five years of large-scale dhfr and dhps mutation surveillance following the phased implementation of artesunate plus sulfadoxine-pyrimethamine in Maputo Province, Southern Mozambique.Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007Are transporter genes other than the chloroquine resistance locus (pfcrt) and multidrug resistance gene (pfmdr) associated with antimalarial drug resistance?Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria.Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia.Comparison of oral artesunate and dihydroartemisinin antimalarial bioavailabilities in acute falciparum malaria.Oral artesunate dose-response relationship in acute falciparum malariaPharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrineArtemether bioavailability after oral or intramuscular administration in uncomplicated falciparum malariaEffect of early detection and treatment on malaria related maternal mortality on the north-western border of Thailand 1986-2010.Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivaxArtesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New GuineaShort-course artesunate treatment of uncomplicated Plasmodium falciparum malaria in Gabon.Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and spaceGrowth-inhibitory effects of artesunate, pyrimethamine, and pamaquine against Babesia equi and Babesia caballi in in vitro cultures.Fosmidomycin, a novel chemotherapeutic agent for malaria.Discovery, mechanisms of action and combination therapy of artemisininDevelopment, evaluation, and application of an in silico model for antimalarial drug treatment and failure.Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand.Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malariaUtility of alkylaminoquinolinyl methanols as new antimalarial drugs.
P2860
Q21090072-83BDCBD0-21AF-4C9A-9C85-5324E42B428CQ22061790-A74A8B9E-EE37-4FD6-B6A9-894836539F79Q22061863-A0EF8ABB-1750-4A11-AF86-877EB0C8C963Q24642214-4324626A-CAF4-4F5A-9432-9B8CD72A33D5Q24812450-C674AD4B-3848-42BD-BF9F-B318E0A64129Q24815752-769963EE-1065-45CA-82C3-B216ED412FC2Q28365926-23C2DF7D-3001-4291-A407-E94EAE9CBF60Q28469025-B9B72F45-1DE5-4F30-A67C-E4B12C83CE7AQ28469264-C20C21E5-EA99-49B3-BD48-5ADBFAAE77C5Q28474447-7A26BB1D-28DA-43FD-A04D-D1773A61C56FQ28534701-982B1AA7-3304-4990-80DC-BA2B8B74BDDEQ28534820-3F9C98BB-D3EA-481B-8BC9-D858096CCEF3Q29615128-1E67F6D5-BBC0-4621-92E8-663CDD513B9EQ30483123-FD608757-5F08-44BB-8A82-3F6DF94C39EEQ30619647-B70E2D9D-705A-48A2-9F96-46C2A592671DQ33381614-08B0562A-43B5-490A-9ECB-2F2B14DDDE5CQ33721985-A5D790C8-D354-444B-B580-74B76CAC72E8Q33754672-12B9F0AC-BA79-429B-88F4-BCC432218710Q33754684-DE6B1B76-DFBA-4E2B-83AD-A8BE1DD63EE4Q33817503-CF954C3E-9860-47FE-ACAD-FE5F5422C745Q33826378-64613A6E-A159-4CB2-8194-BD38B439ACDFQ33836765-9F227612-B2DE-48B6-A168-C21402D5EBE1Q33864553-BA0049A8-BB80-4C31-A531-F8F94F7ED698Q33938016-E8DEEEDD-CA50-4467-9622-8D6659E6CAC1Q34106127-EAF487D8-9163-47C8-B283-658FC2B04267Q34113505-6492505B-C6E8-4068-BA77-4501E3AD151DQ34221884-DFE87666-6075-49E9-8632-A8DD8EC2F9B2Q34230161-ADC76A56-28D3-4E06-B58A-EE80BD7F2031Q34344807-0407B2D8-55ED-4874-B1CE-0FCD4C81DA9CQ34360576-84BBD279-98AB-4D61-99CF-56C09DA4B0F3Q34509744-F17998D5-985E-4EF5-981C-D4DD858BCDF7Q34734703-F1187BD7-F0AE-4EE7-89C2-FB23678A3E2DQ34743254-5A1FC206-045A-4D76-916C-884A52609D4CQ34820970-33DD98B0-2828-4911-9D76-BC5A3FB959FBQ34823125-4B8F7321-0C4F-48D8-9555-D0C7144AB022Q35006418-62755062-44A0-4968-B3DB-25896FA4E2ABQ35065737-70DEBFF5-1D05-4BDF-B9D6-C9D1D6D0FD36Q35069117-BA8F7258-D3CC-4C30-AE2B-EE236D034F9DQ35112348-37B16A7E-6BD1-4687-95BB-BBF6BA9BD036Q35215427-5DB2A8E6-7272-4382-9AF7-7F62E8C42713
P2860
Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Plasmodium falciparum antimala ...... use of artesunate-mefloquine.
@ast
Plasmodium falciparum antimala ...... use of artesunate-mefloquine.
@en
type
label
Plasmodium falciparum antimala ...... use of artesunate-mefloquine.
@ast
Plasmodium falciparum antimala ...... use of artesunate-mefloquine.
@en
prefLabel
Plasmodium falciparum antimala ...... use of artesunate-mefloquine.
@ast
Plasmodium falciparum antimala ...... use of artesunate-mefloquine.
@en
P2093
P2860
P50
P921
P1476
Plasmodium falciparum antimala ...... use of artesunate-mefloquine.
@en
P2093
A Brockman
D G Heppner
M van Vugt
T Wimonwattrawatee
P2860
P304
P356
10.1016/S0035-9203(00)90080-4
P577
2000-09-01T00:00:00Z